During Tuesday’s current trade, Invesco Mortgage Capital Inc (NYSE:IVR)’s shares decline -0.31% to $15.86.
Invesco Mortgage Capital Inc (IVR) declared that its Board of Directors declared quarterly dividends on shares of its common stock and Series A and Series B preferred stock.
Common Stock Dividend
The Company’s Board of Directors declared a cash dividend of $0.45 per share of common stock for the second quarter of 2015. The dividend will be paid on July 28, 2015 to stockholders of record on June 26, 2015, with an ex-dividend date of June 24, 2015.
Series A Preferred Stock Dividend
The Board of Directors declared a quarterly cash dividend on its 7.75% Series A Preferred Stock of $0.4844 per share. The dividend will be paid on July 27, 2015 to stockholders of record on July 1, 2015.
Invesco Mortgage Capital Inc., a real estate investment trust, focuses on investing in, financing, and managing residential and commercial mortgage-backed securities and mortgage loans. It invests in residential mortgage-backed securities for which a U.S. government agency guarantees payments of principal and interest on the securities; residential mortgage-backed securities that are not issued or guaranteed by a U.S. government agency; commercial mortgage-backed securities; residential and commercial mortgage loans; and other real estate-related financing arrangements.
Keryx Biopharmaceuticals (NASDAQ:KERX)‘s shares drop -1.46% to $10.12, during the current trading session Tuesday’s, hitting its highest level.
Keryx Biopharmaceuticals, Inc., (KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease, recently declared that it will present at the JMP Securities Life Sciences Conference in New York City on Wednesday, June 24, 2015 at 2:30 p.m. EDT.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
In an afternoon trade, Stillwater Mining Company (NYSE:SWC)‘s shares surge 0.96% to $12.64.
Stillwater Mining Company (SWC) stated recently that union employees at the Company’s Stillwater Mine and Columbus processing facility, represented by the USW International Union Local 11-0001, have failed to ratify the tentative labor agreement reached on May 27, 2015. The Negotiating Committee for the Union and the representative for USW International had unanimously recommended that their members approve the tentative agreement.
Commenting on the outcome of the vote, Mick McMullen, the Company’s President and Chief Executive Officer stated, “We are disdesignated that the tentative agreement was not ratified. Based on this decision by the union members, Company administration is considering all alternatives to create a situation that will best promote the long-term economic viability of operations at the Stillwater Mine and Columbus processing facility. The current contract will expire at midnight on June 12, 2015. The Company will meet its obligations and work with the Negotiating Committee for the Union and the representative for USW International in an effort to find a solution that is reasonable for all stakeholders.”
Stillwater Mining Company engages in the development, extraction, processing, smelting, and refining of platinum group metals (PGMs). It operates through Mine Production, PGM Recycling, Canadian Properties, and South American Properties segments. The company primarily explores for palladium, platinum, and associated metals, in addition to for nickel, copper, gold, silver, and rhodium ores.
Health Care REIT, Inc. (NYSE:HCN), during its Tuesday’s current trading session -0.47% loss and closed at $67.23.
Health Care REIT, Inc. (HCN) and partner Revera, Inc. declared the acquisition of another Canadian seniors housing portfolio, by offering to acquire Regal Lifestyle Communities Inc. RLC) for CAD$12.00 per share, or CAD$766 million — which equates to a US$623 million total enterprise value.
According to the declarement, “Regal is a publicly traded Canadian corporation that owns and operates 23 high-quality seniors housing communities with over 3,600 units. This private pay portfolio comprises 13 communities in Ontario, seven in Quebec, and one each in British Columbia, Saskatchewan and Newfoundland. About 83% of the portfolio’s net operating income is derived from Toronto, Montreal, Ottawa and Vancouver.”
The acquisition was done on behalf of an existing 75/25 JV between majority owner HCN and Revera. Revera owns or operates more than 500 properties across Canada, the United States and the United Kingdom, serving more than 45,000 people.
Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The firm primarily invests in senior living and health care properties. It invests across the full spectrum of health care real estate, counting senior living communities, medical office buildings, inpatient and outpatient medical centers and life science facilities. The firm conducts in-house research to make its investments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
